+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Prothrombin"

Acquired Hemophilia A - Pipeline Insight, 2024 - Product Thumbnail Image

Acquired Hemophilia A - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 50 Pages
  • Global
From
Hemophilia A - Pipeline Insight, 2024 - Product Thumbnail Image

Hemophilia A - Pipeline Insight, 2024

  • Clinical Trials
  • February 2024
  • 80 Pages
  • Global
From
Factor Xa inhibitors - Pipeline Insight, 2024 - Product Thumbnail Image

Factor Xa inhibitors - Pipeline Insight, 2024

  • Drug Pipelines
  • January 2024
  • 60 Pages
  • Global
From
Factor II (Prothrombin) Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

Factor II (Prothrombin) Inhibitor - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
From
From
From
Loading Indicator

Prothrombin is a hematological drug used to treat and prevent blood clotting disorders. It is a form of vitamin K-dependent clotting factor, which is produced in the liver and is essential for normal blood clotting. Prothrombin is used to treat and prevent conditions such as deep vein thrombosis, pulmonary embolism, and stroke. It is also used to prevent bleeding in patients with liver disease or who are taking anticoagulants. Prothrombin is available in both injectable and oral forms. The prothrombin market is highly competitive, with a number of companies offering products. Some of the major players in the market include Pfizer, Novo Nordisk, Sanofi, Bayer, and Merck. These companies offer a range of products, including injectable and oral forms of prothrombin, as well as generic versions. Show Less Read more